High call volumes
Our provider services may be experiencing higher than normal call volumes this week. We encourage you to utilize alternative forms of communication, such as the Availity Essentials Provider Portal
NextBlue of North Dakota Medicare Advantage Plan would like to inform providers of a new part B drug which will require prior authorization as of August 1, 2024. The Federal Drug Administration (FDA) just approved HCPCS code J9999: Rytelo™ (imetelstat) to require prior approval effective on/after August 1, 2024.
The NextBlue Part B drug list will be updated shortly, which is located on the NextBlue Provider Website under Provider Resources | Prior Authorizations (nextbluend.com).
Questions?
Contact the NextBlue of North Dakota Provider Call Center at 1-844-753-8039.
